Wednesday, 14 October 2026Editorial standards
GLP-1 News

Daily reporting on GLP-1 medicines and weight

Hany Rambod warns bodybuilders over GLP-1 muscle loss

The bodybuilding coach says appetite suppression can make it harder to maintain protein intake, with resistance training an important part of protecting muscle.

Eleanor WhitcombeEleanor WhitcombeHealth Editor3 min read
Bodybuilder lifting dumbbells in a gym, illustrating resistance training amid concerns about GLP-1 muscle loss
Bodybuilder lifting dumbbells in a gym, illustrating resistance training amid concerns about GLP-1 muscle loss

What Hany Rambod said about GLP-1 muscle loss

Bodybuilding coach Hany Rambod has warned athletes considering GLP-1 medicines that appetite suppression can make it harder to eat enough to maintain muscle. He raised the concern during a recent episode of The Truth Podcast, according to reporting by Generation Iron; the supplied report gives no broadcast date.

His warning centres on a practical consequence of eating less: protein intake may fall alongside overall calorie consumption. For bodybuilders trying to reduce fat while retaining muscular size, that can work against the purpose of their training.

The comments are advice from a coach, rather than findings from a new clinical study. Generation Iron describes Rambod as a 25-time Olympia-winning coach, placing his remarks in the context of competitive bodybuilding rather than general prescribing guidance.

How GLP-1 weight loss differs from muscle preservation

GLP-1 medicines act on pathways involved in appetite and blood sugar regulation. By helping people feel less hungry, they can reduce food intake and support weight loss in appropriate patients. Ozempic, the brand discussed in the report, contains semaglutide and is a diabetes medicine; semaglutide is also marketed for weight management under the Wegovy brand.

A reduction in body weight does not, however, measure fat loss alone. Weight lost during calorie restriction can include lean tissue, a category that includes muscle but is not identical to it. That distinction matters when interpreting claims about how much muscle a treatment might cost someone.

Generation Iron notes that resistance training and sufficient protein can help preserve muscle during calorie restriction, without guaranteeing that all muscle loss will be prevented. The report does not give a percentage of muscle loss attributable to GLP-1 treatment or establish that bodybuilders face a particular quantified risk.

For competitors, body composition has a direct bearing on their sport: the aim is to display muscular development while reducing body fat. Their nutritional priorities are therefore not interchangeable with those of every patient receiving treatment for obesity or diabetes. Our coverage of GLP-1 protein intake and diet quality examines the wider nutritional questions raised by reduced appetite.

Why Hany Rambod puts protein alongside weight training

Rambod urged those considering treatment to work with a qualified physician who could explain the advantages and disadvantages of the available medicines. His comments did not identify one drug as the preferred option for bodybuilders.

On preserving muscle, he paired continued weight training with adequate protein rather than presenting either as sufficient on its own. His concern was that a diminished desire to eat could disrupt the habits athletes rely on to sustain their physiques.

Earlier in the podcast, Rambod recommended at least one gram of protein per pound of body weight for athletes seeking muscle growth, according to Generation Iron. That figure needs its original context: it was a bodybuilding recommendation, not a requirement established for everyone using a GLP-1 medicine.

The report notes that individual protein needs vary with body composition, training demands and medical circumstances. Readers should therefore distinguish a coach’s target for building muscle from a nutritional plan tailored to a patient’s treatment. The limits of drawing broad conclusions about body composition are also explored in our report on GLP-1 muscle loss and a small semaglutide study.

What bodybuilders considering GLP-1 treatment should discuss next

The next step Rambod identifies is a medical discussion before choosing a medicine. His remarks do not establish which treatment, dose or dietary target would be suitable for an individual athlete.

For that discussion, the unresolved issue is how a person’s treatment goals fit with their ability to eat adequately and continue training. The supplied report contains no bodybuilder-specific treatment protocol and no comparative evidence showing which GLP-1 medicine best preserves muscle in this group. It supports attention to nutrition and resistance exercise, not a promise that either will eliminate changes in lean tissue.

Why this matters

For people taking GLP-1 medicines, a smaller appetite can change more than the amount they eat: it can also make adequate nutrition harder to maintain. Rambod’s comments draw attention to that practical issue, particularly for athletes seeking to retain muscle while reducing fat. The important boundary is between a bodybuilding recommendation and individual medical advice. Protein and resistance training can support muscle preservation, but a coach’s dietary target should not be treated as a universal prescription for patients.

Frequently asked questions

Do GLP-1 drugs cause muscle loss?
Some weight lost during GLP-1 treatment may come from lean tissue rather than fat alone. Lean tissue is not synonymous with muscle. The report does not quantify muscle loss or establish an individual patient’s risk.
What did Hany Rambod say about GLP-1 drugs?
Rambod warned that appetite suppression can reduce protein intake, making muscle preservation harder. He urged bodybuilders to continue resistance training, eat adequate protein and consult a qualified doctor about treatment options.
How much protein should you eat on GLP-1 drugs?
The report gives no universal GLP-1 protein target. Rambod’s recommendation of at least one gram per pound of body weight concerned athletes building muscle. Individual needs vary with body composition, training and medical circumstances.
Can weight training prevent muscle loss on GLP-1 drugs?
Resistance training and sufficient protein can help preserve muscle during calorie restriction. Neither guarantees that all muscle loss will be prevented.
Why can eating less put muscle at risk?
Reduced food intake can also mean reduced protein intake. Rambod highlighted this as a concern for athletes who depend on sufficient nutrition to maintain their muscle while losing weight.
Which GLP-1 drug did Hany Rambod recommend for bodybuilders?
The report does not identify a preferred medicine. Rambod advised people to discuss the advantages and disadvantages of available treatments with a qualified physician.

Sources

This report draws on the following original reporting:

Topics: GLP-1 · Muscle loss · Protein · Resistance training · Ozempic

This article is for information only and is not medical advice.

Related coverage